Synthekine Announces $107.5 Million Oversubscribed Series B Financing to Support Lead Programs to Clinical Proof of Concept, Advance Preclinical Programs and Platform

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3cvgQ5N
via IFTTT